Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amikacin Combination for Disseminated MAC in HIV
NCT00000641Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amikacin in Mycobacterium avium complex infection (MAC), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
amikacin
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00000641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000641.